Canagold Resources Ltd (TSX:CCM, OTCQB:CRCUF) has released results of a feasibility study for its 100%-owned New Polaris gold-antimony project in northwestern British Columbia, outlining strong project economics, low capital costs, and significant upside from critical mineral antimony.
The study estimates an after-tax net present value (NPV) of C$425 million and an internal rate of return (IRR) of 30.9% at a base case gold price of US$2,500 per ounce. Using a spot gold price of US$3,300, the NPV rises to C$793 million with a 47.3% IRR.
Shares of Opendoor Technologies Inc (NASDAQ: OPEN) soared more than 85% on Monday as a wave of retail investor enthusiasm sent the stock to its highest level in over a year, reviving memories of the GameStop Corp (NYSE:GME) trading mania of 2021.
The online real estate platform’s stock has jumped 188% over the past week, rising from just above $0.50 in late June to $4.22 at midday Monday.
Excellon Resources Inc (TSX:EXN, OTCQB:EXNRF) announced that it has mobilized a mining contractor and commenced underground rehabilitation activities at its Mallay Silver Mine in Peru.
The company said the work is a key step in its plan to restart operations at the past-producing mine and return to silver production.
Protalix BioTherapeutics Inc (NYSE-A:PLX) has announced the appointment of Gilad Mamlok as senior vice president and chief financial officer, succeeding Eyal Rubin.
Mamlok has already joined the company and is currently working alongside Rubin, the company said. Following the end of his tenure, Rubin will remain available to the company as needed until October 2025.
American Resources Corp (NASDAQ:AREC) and its subsidiary ReElement Technologies have signed a memorandum of understanding (MOU) with Impossible Metals Inc to jointly develop a vertically integrated US-based supply chain for critical minerals, the companies said on Monday.
The partnership aims to combine Impossible Metals' deep-sea nodule harvesting technology with ReElement's refining capabilities to deliver copper, cobalt, nickel, manganese, and rare earth elements from seabed to finished product within the US.
Century Lithium Corp. (TSX-V:LCE, OTCQX:CYDVF) announced that Alpha-En Corporation has successfully converted lithium carbonate from the company's Nevada project into battery-grade lithium-metal anodes.
The lithium carbonate used in the conversion was produced at Century Lithium’s wholly owned Angel Island project in Esmeralda County and processed at the company’s Demonstration Plant in Nye County, also in Nevada.
Millennial Potash Corp (TSX-V:MLP, OTCQB:MLPNF) has announced a non-brokered private placement of approximately $6 million, issuing about 3.87 million units priced at $1.55 each.
The proceeds from the offering will support further exploration and development work at Millennial’s Banio potash project and will also be used for general working capital.
Digi Power X Inc (NASDAQ:DGXX, TSX-V:DGX) announced that it has entered into a definitive securities purchase agreement to raise approximately US $15 million in gross proceeds through a registered direct offering of common stock.
The offering involves the sale of approximately 4.8 million shares, or pre-funded warrants in lieu thereof, at US$3.12 per share to a single new fundamental institutional investor.
Graphene Manufacturing Group Ltd (TSX-V:GMG, OTCQX:GMGMF) has added engineering academic Professor Emeritus Doug Hargreaves AM to its Technical Advisory Committee, the company said Monday.
Hargreaves, a professor emeritus at Queensland University of Technology and a member of the Order of Australia, brings decades of engineering expertise and industry connections. He previously served as National President of Engineers Australia and is currently Executive Officer of the Australian Council of Engineering Deans.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said that its experimental nasal treatment for Alzheimer’s disease showed promising results in a patient, helping reduce brain inflammation and possibly aiding in the removal of harmful protein buildup linked to the disease.
The company’s lead drug, intranasal foralumab, is a fully human antibody designed to regulate the immune system.
Gunnison Copper Corp (TSX:GCU, OTCQB:GCUMF) has closed its previously announced non-brokered private placement, raising gross proceeds of C$8.66 million through the sale of 28.87 million units priced at C$0.30 each.
Each unit in the offering comprises one share and one common share purchase warrant, with each warrant exercisable at C$0.45 until July 2028.
NanoViricides (NYSE-A:NNVC) said on Monday that its broad-spectrum antiviral candidate, NV-387, showed strong effectiveness in preclinical studies using a humanized animal model.
The Connecticut-based biotech firm reported increased survival in mice infected with a lethal dose of the measles virus by 130%, extending average survival time to 17 days compared to 7.4 days in untreated animals.
Tertiary Minerals PLC (AIM:TYM, OTC:TTIRF) shares rose 5% after the company announced it has started a fresh drilling campaign at Target A1 on its Mushima North project in Zambia.
The new programme will see up to 1,500 metres of air core and reverse circulation drilling to build on promising results from late 2024, where earlier holes uncovered significant silver, copper and zinc mineralisation.
Shares in Anglo Asian Mining Plc (LSE:AAZ, OTC:AGXKF) rose 7% after the group confirmed the start of production at its Demirli copper mine in Azerbaijan’s Karabakh Economic Region.
This marks the second new mine to come online for the company this year and strengthens its ambition to become a mid-tier, multi-asset copper producer.
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) said it is gearing up for a busy year, as it reported stable revenue for the year to June 30.
Updating on trading, it said it has submitted a marketing authorisation application for its Grass MATA MPL immunotherapy product and is preparing for a potential launch in the 2026 financial year.
Tertiary Minerals PLC (AIM:TYM, OTC:TTIRF) has begun drilling at Target A1, part of its Mushima North project in Zambia, as it seeks to build momentum in the search for silver, copper and zinc.
The company said it has launched a programme of up to 1,500 metres of air core and reverse circulation drilling to follow up on encouraging results from late last year.
Anglo Asian Mining Plc (LSE:AAZ, OTC:AGXKF) has started production at its Demirli copper mine in the Karabakh Economic Region of Azerbaijan, marking the second new mine to enter production for the group this year.
The move underpins the company's strategy to become a multi-asset, mid-tier copper producer.
Imaging Biometrics Ltd (LSE:IBAI, OTCQB:IQAIF) has announced a soft close to its phase I trial of oral gallium maltolate for adults with relapsed or treatment-resistant glioblastoma, signalling that the study has reached sufficient enrollment to progress to the next stage.
The company said no new patients will be recruited at this point, but the trial remains active for those already participating.
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has released its quarterly activity statement for the fourth quarter (Q4) of financial year 2025, revealing a solid 12% year-on-year revenue increase but a dip in Q4 figures primarily attributed to the seasonal decline in US flu cases.
Despite the quarterly revenue dip, the company made significant progress in its regulatory and commercial initiatives, including a milestone exclusive distribution deal for its FebriDx® point-of-care diagnostic product.
American Rare Earths Ltd (ASX:ARR, OTCQB:ARRNF) has announced the resignation of chief executive officer and executive director Chris Gibbs, effective July 31, 2025. Gibbs, who has played a significant role in advancing the Halleck Creek Project since 2021, departs as the company enters its next phase of growth.
Chris Gibbs has served in both executive and non-executive capacities since 2021 and was instrumental in strengthening ARR’s North American presence and progressing the Halleck Creek Project.
Clinical-stage biotechnology company Tryptamine Therapeutics Ltd (ASX:TYP, OTC:TYPTF), has launched patient recruitment for a first-of-its-kind clinical trial assessing TRP-8803, an IV-infused psilocin, as a potential treatment for Binge Eating Disorder (BED).
This trial, in collaboration with Swinburne University, aims to explore the safety, feasibility, and efficacy of TRP-8803 when administered alongside psychotherapy for adults living with BED.
Veteran mining executives Steve Promnitz and Brett Lynch will join Resolution Minerals Ltd (ASX:RML, OTC:RLMLF) as senior strategic advisers to lead the company’s expansion into the United States critical minerals sector. Promnitz is best known for transforming Lake Resources from a A$1 million explorer into a A$3 billion lithium developer. Lynch, the former managing director of Sayona Mining Ltd, played a central role in its emergence as a multi-billion dollar North American lithium producer.
The move is a major strategic inflection point for the RML, which is preparing to launch a fully permitted drilling campaign at its Horse Heaven Project in Idaho. Both executives have a proven track record of generating more than A$7 billion in value across ASX-listed resource companies and bring deep networks and US operational experience to the table.
Firebird Metals Ltd (ASX:FRB, OTC:FRBMF) has bolstered its intellectual property (IP) portfolio with the granting of two pivotal patents for proprietary lithium manganese iron phosphate (LMFP) preparation methods.
The patents, which were fast-tracked through China’s patent process, are central to Firebird's strategy in advancing the development of next-generation battery materials as it establishes itself as a leader in Western LMFP development.
Two US-based industry veterans will help accelerate archTIS Ltd (ASX:AR9, OTCQB:ARHLF)'s expansion into North America’s defence and government markets. The strategic hires represent the first deployment of funds raised in the company’s recent A$7.5 million placement and align with its goal to grow global sales and implementation capability.
Erik Hanson and Darroll Walsh will lead customer-facing activities across technical sales, onboarding, implementation, and success initiatives. Their arrival follows recent momentum with the US Department of Defence and signals archTIS’ commitment to building a dedicated US presence.